SmithKline Beecham’s Bactroban (mupirocin)
Executive Summary
Topical antibiotic ointment will be co-promoted to U.S. dermatologists by Rhone-Poulenc Rorer's Dermik Labs subsidiary, SB announces Nov. 4. SmithKline Beecham will continue to market Bactroban, which had sales of $60 mil. in 1991, to general practitioners and pediatricians.